MACK ANTHONY P. enters VIRPAX PHARMACEUTICALS, INC. with 2.88M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 2/16/2021ACC: 0001213900-21-009777
DirectorOfficer· Chief Executive Officer
Since Feb 2021
2.88M
Baseline shares
5% direct
151.69K
Direct ownership
1 position
60.67K
Derivative underlying
2 instruments
2
Security positions
2.73M indirect
Non-Derivative Holdings2
Common Stock, $0.00001 par value per share
DirectShares owned151.69K
Common Stock, $0.00001 par value per share
IndirectShares owned2.73M
Total
151.69K direct·2.73M indirect2.88M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.00001 par value per share | 151.69K | Direct |
| Common Stock, $0.00001 par value per share | 2.73M | Indirect |
| Total | 2.88M | 151.69K direct·2.73M indirect |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common Stock, $0.00001 par value per share
Underlying shares
20.23K
Shares owned
N/A
Exercise price
9.89
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock, $0.00001 par value per share
Underlying shares
40.45K
Shares owned
N/A
Exercise price
9.89
Expiration
—
Exercise window
—
Total
Underlying
60.67K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock, $0.00001 par value per share | 9.89 | — | — | 20.23K | N/A |
| Stock Option (right to buy) Direct | Common Stock, $0.00001 par value per share | 9.89 | — | — | 40.45K | N/A |
| Total | 60.67K | 0.00 | ||||